alfuzosin vs potassium citrate
Side-by-side comparison of alfuzosin and potassium citrate Data from FDA drug databases (Orange Book, NDC Directory, recalls, shortages) covering 20,000+ approved drugs, plus CMS pricing; see our methodology.
Uroxatral
Urocit-K
Alfuzosin is a medicine that helps men with enlarged prostate glands. It relaxes the muscles in the prostate and bladder, making it easier to urinate.
Potassium citrate is a medicine that helps manage kidney problems. It can help prevent kidney stones and balance the acid levels in your urine.
This medicine treats the symptoms of benign prostatic hyperplasia (BPH), also known as an enlarged prostate. BPH can cause problems with urination, such as difficulty starting or stopping, frequent urination, and feeling like you can't empty your bladder. Alfuzosin helps to improve these symptoms.
This medicine is used to manage renal tubular acidosis (RTA) with calcium stones. It also treats hypocitraturic calcium oxalate nephrolithiasis, which is a condition that causes calcium oxalate kidney stones. Potassium citrate can also help with uric acid kidney stones, whether or not you also have calcium stones.
Alfuzosin belongs to a class of drugs called alpha-1 blockers. It works by relaxing the muscles in the prostate and bladder neck. This relaxation allows urine to flow more freely, relieving the symptoms of BPH.
Potassium citrate works by increasing the amount of citrate in your urine. This makes your urine less acidic. Less acidic urine helps prevent kidney stones from forming.
- • Dizziness
- • Upper respiratory tract infection
- • Headache
- • Fatigue
- • Abdominal discomfort
- • Vomiting
- • Diarrhea
- • Loose bowel movements
- • Nausea
- The medicine is not working 112
- Using the medicine for something it's not approved for 96
- Difficulty breathing 89
- The medicine is interacting with another medicine 87
- Tiredness 87
- Medication not working 425
- Tiredness 346
- Feeling sick to your stomach 319
- Loose, watery stools 310
- Discomfort 300
Alfuzosin can cause your blood pressure to drop suddenly when you stand up, leading to dizziness or fainting. Be careful when standing up quickly, especially when you first start taking this medicine. If you have chest pain (angina), tell your doctor immediately. This medicine may also affect your heart rhythm. Tell your doctor if you have a history of heart problems.
This medicine can cause high potassium levels in your blood, which can be dangerous. You should not take this medicine if you have kidney failure, uncontrolled diabetes, or other conditions that make it hard for your body to get rid of potassium. If you have severe vomiting, stomach pain, or bleeding, stop taking this medicine and contact your doctor immediately.
This medicine is only for men and is not intended for use in women. It is not known if alfuzosin can harm an unborn baby or pass into breast milk.
It is not known if this medicine will harm an unborn baby. Talk to your doctor if you are pregnant or plan to become pregnant. It is also not known if this medicine passes into breast milk, so talk to your doctor if you are breastfeeding.
How to Read This alfuzosin vs potassium citrate Comparison
alfuzosin is classified in the Alpha-1 Blocker (BPH) drug class, while potassium citrate sits within the Urinary Alkalinizer class. Drugs from different classes work through distinct mechanisms, so a head-to-head comparison illustrates trade-offs rather than equivalence. Both drugs are prescription-only, so a licensed provider must authorize use.
Adverse event totals above are pulled from the FDA's Adverse Event Reporting System (FAERS). For these top-ranked reactions alone, alfuzosin has 471 submissions while potassium citrate has 1,700. Those figures reflect cumulative reporting volume — not per-patient risk — so older, widely dispensed drugs typically look worse on count alone. No direct interaction between these two drugs is listed in our FDA-derived dataset, though co-prescription still warrants pharmacist review. Serious warnings, pregnancy guidance, and contraindications can differ even when indications overlap.
A table cannot substitute for clinical judgment. Effectiveness, tolerability, drug-drug interactions with your other medications, kidney and liver function, pregnancy status, insurance formulary, and price all feed into a decision that only a licensed prescriber can make responsibly. Data here is sourced from FDA Structured Product Labels (SPL) and FAERS, both of which update as manufacturers and clinicians submit new information. This page is for educational purposes only, is not medical advice, and should not be used to self-switch between alfuzosin and potassium citrate — always consult your physician or pharmacist first.
Important: This comparison is for informational purposes only. Drug effects vary between individuals. Always consult your doctor or pharmacist for personalized medical advice.